
FASN Inhibitor – TVB-2640
Indication – NASH
Phase 2
FASN Inhibitor – TVB-2640
Indication – Oncology
Phase 2
FASN Inhibitor – TVB-3567
Indication – Undisclosed
Preclinical
Posters & Publications
Phase II Investigation of TVB-2640 (denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
Clinical Cancer Research
Read More